{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:55:54Z","timestamp":1778712954856,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T00:00:00Z","timestamp":1288483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T00:00:00Z","timestamp":1288483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10067-010-1612-2","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T22:50:34Z","timestamp":1288824634000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature"],"prefix":"10.1007","volume":"30","author":[{"given":"Freke","family":"Wink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieternella M.","family":"Houtman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim L. Th. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,31]]},"reference":[{"key":"1612_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","volume":"57","author":"JC Brouet","year":"1974","unstructured":"Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M (1974) Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 57:775\u2013788","journal-title":"Am J Med"},{"issue":"6","key":"1612_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0002-9343(66)90200-2","volume":"40","author":"M Meltzer","year":"1966","unstructured":"Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N (1966) Cryoglobulinemia: a clinical and laboratory study. Am J Med 40(6):837\u2013856","journal-title":"Am J Med"},{"issue":"12","key":"1612_CR3","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#","volume":"42","author":"P Lamprecht","year":"1999","unstructured":"Lamprecht P, Gause A, Gross WL (1999) Cryoglobulinemic vasculitis. Arthritis Rheum 42(12):2507\u20132516","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1612_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","volume":"63","author":"GL Plosker","year":"2003","unstructured":"Plosker GL, Figgitt DP (2003) Rituximab: a review of its use in non-Hodgkin\u2019s lymphoma and chronic lymphocytic leukaemia. Drugs 63(8):803\u2013843","journal-title":"Drugs"},{"key":"1612_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/ard.61.10.883","volume":"61","author":"MJ Leandro","year":"2002","unstructured":"Leandro MJ, Edwards JC, Cambridge G (2002) Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 61:883\u2013888","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1612_CR6","first-page":"2109","volume":"32","author":"J Higashida","year":"2005","unstructured":"Higashida J, Wun T, Schmidt S, Naguwa SM, Tuscano JM (2005) Safety and efficacy of rituximab in patients with rheumatoid arthritis refractory to disease modifying antirheumatic drugs and anti-tumor necrosis factor-alpha treatment. J Rheumatol 32(11):2109\u20132115","journal-title":"J Rheumatol"},{"issue":"3","key":"1612_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/rheumatology\/keh503","volume":"44","author":"H Nehme-Schuster","year":"2005","unstructured":"Nehme-Schuster H, Korganow AS, Pasquali JL, Martin T (2005) Rituximab inefficiency during type I cryolobulinaemia. Rheumatology (Oxford) 44(3):410\u2013411","journal-title":"Rheumatology (Oxford)"},{"key":"1612_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1093\/rheumatology\/kel387","volume":"46","author":"H Cohen","year":"2007","unstructured":"Cohen H, Green S, Jones S, Amos N, William BD (2007) Lack of efficacy of rituximab in a patient with essential mixed cryoglobulinaemia. Rheumatology 46:366\u2013367","journal-title":"Rheumatology"},{"key":"1612_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12016-007-8019-0","volume":"34","author":"D Roccatello","year":"2008","unstructured":"Roccatello D, Baldovino S, Rossi D, Giachino O, Mansouri M (2008) Rituximab as a therapeutic tool in severe mixed cryoglobulinemia. Clin Rev Allergy Immunol 34:111\u2013117","journal-title":"Clin Rev Allergy Immunol"},{"key":"1612_CR10","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1182\/blood-2002-09-2856","volume":"101","author":"F Zaja","year":"2003","unstructured":"Zaja F, De Vita S, Mazzaro C, Sacco S, Damiani D (2003) Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101:3827\u20133834","journal-title":"Blood"},{"key":"1612_CR11","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2002-10-3162","volume":"101","author":"D Sansonno","year":"2003","unstructured":"Sansonno D, De Re V, Lauletta G, Tucci FA, Boiocchi M, Dammacco F (2003) Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon \u03b1 with an anti-CD20. Blood 101:3818\u20133826","journal-title":"Blood"},{"issue":"12","key":"1612_CR12","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1002\/art.25000","volume":"60","author":"D S\u00e8ne","year":"2009","unstructured":"S\u00e8ne D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P (2009) Rituximab may form a complex with IgM\u03ba mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum 60(12):3848\u20133855","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1612_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3816\/CLM.2006.n.052","volume":"7","author":"AH Bryce","year":"2006","unstructured":"Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV (2006) Response to rituximab in patients with type II cryoglobulinemia. Clin Lymphoma Meyloma 7(2):140\u2013144","journal-title":"Clin Lymphoma Meyloma"},{"key":"1612_CR14","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/ard.61.10.922","volume":"61","author":"K Arzoo","year":"2006","unstructured":"Arzoo K, Sadeghi S, Liebman HA (2006) Treatment of refractory antibody mediated autoimmune disorders with an anti-CD20 monoclonal antibody (rituximab). Ann Rheum Dis 61:922\u2013924","journal-title":"Ann Rheum Dis"},{"key":"1612_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ndt\/gfh564","volume":"20","author":"M Koukoulaki","year":"2005","unstructured":"Koukoulaki M, Abeygunasekara SM, Smith KGC, Jayne DRW (2005) Remission of refractory hepatitis C-negative cryoglobulinaemic vasculitis after rituximab and infliximab. Nephrol Dial Transplant 20:213\u2013216","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1612_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1590\/S1413-86702007000100038","volume":"11","author":"TCG Rego","year":"2007","unstructured":"Rego TCG, Massumoto CM, Batista RS, De Moura LH, Soares LMC, Gomes AP (2007) The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia. Braz J Infect Dis 11(1):174\u2013175","journal-title":"Braz J Infect Dis"},{"key":"1612_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1136\/ard.2002.004929","volume":"62","author":"P Lamprecht","year":"2003","unstructured":"Lamprecht P, Lerin-Lozano C, Merz H, Dennin RH, Gause A, Voswinkel J, Peters SA, Gutzeit O, Arlt AC, Solbach W, Gross WL (2003) Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 62:1230\u20131233","journal-title":"Ann Rheum Dis"},{"key":"1612_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ajh.21330","volume":"84","author":"J Ruch","year":"2009","unstructured":"Ruch J, McMahon B, Ramsey G, Kwaan HC (2009) Catastrophic multiple organ ischemia due to an anti-Pr cold agglutinin developing in a patient with mixed cryoglobulinemia after treatment with rituximab. Am J Hematol 84:120\u2013122","journal-title":"Am J Hematol"},{"issue":"5","key":"1612_CR19","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/00004836-200605000-00018","volume":"40","author":"J Pekow","year":"2006","unstructured":"Pekow J, Chung RT (2006) Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab. J Clin Gastroenterol 40(5):450","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"1612_CR20","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1053\/j.ajkd.2003.12.057","volume":"43","author":"E Ghijsels","year":"2004","unstructured":"Ghijsels E, Lerut E, Vanrenterghem Y, Kuypers D (2004) Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure. Am J Kidney Dis 43(5):e34\u2013e38","journal-title":"Am J Kidney Dis"},{"key":"1612_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00296-007-0462-y","volume":"28","author":"A Braun","year":"2008","unstructured":"Braun A, Neumann T, Oelzner P, Hein G, Gr\u00f6ne HJ, Ziemer M, Wolf G (2008) Cryoglobulinaemia type III with severe neuropathy and immune complex glomerulonephritis: remission after plasmapheresis and rituximab. Rheumatol Int 28:503\u2013506","journal-title":"Rheumatol Int"},{"issue":"6","key":"1612_CR22","first-page":"1197","volume":"33","author":"FZJ Cai","year":"2006","unstructured":"Cai FZJ, Ahern M, Smith M (2006) Treatment of cryoglobulinemia associated peripheral neuropathy with rituximab. J Rheumatol 33(6):1197\u20131198","journal-title":"J Rheumatol"},{"issue":"suppl 1","key":"1612_CR23","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/S1590-8658(07)80026-0","volume":"39","author":"M Massari","year":"2007","unstructured":"Massari M, Catania A, Magnani G (2007) Efficacy and risk of rituximab in type II mixed cryoglobulinemia: a significant case report. Dig Liver Dis 39(suppl 1):S134\u2013S135","journal-title":"Dig Liver Dis"},{"issue":"7","key":"1612_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ncpneph0823","volume":"4","author":"S Pandrangi","year":"2008","unstructured":"Pandrangi S, Singh A, Wheeler DE, Rossi NF (2008) Rituximab treatment for a patient with type I cryoglobulinemic glomerulonephritis. Nat Clin Pract Nephrol 4(7):393\u2013397","journal-title":"Nat Clin Pract Nephrol"},{"issue":"7","key":"1612_CR25","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/MCG.0b013e3180f60b7a","volume":"42","author":"JT Evans","year":"2008","unstructured":"Evans JT, Shepard MM, Oates JC, Self SE, Reuben A (2008) Rituximab-responsive cryoglobulinemic glomerulonephritis in a patient with autoimmune hepatitis. J Clin Gastroenterol 42(7):862\u2013863","journal-title":"J Clin Gastroenterol"},{"key":"1612_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11239-008-0195-0","volume":"27","author":"S Pasa","year":"2009","unstructured":"Pasa S, Altintas A, Cil T, Danis R, Ayyildiz O, Muftuoglu E (2009) A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab. J Thromb Thrombolysis 27:220\u2013222","journal-title":"J Thromb Thrombolysis"},{"key":"1612_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","volume":"80","author":"G Basse","year":"2005","unstructured":"Basse G, Ribes D, Kamar N, Mehrenberger M, Esposito L, Guitard J (2005) Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation 80:1560\u20131564","journal-title":"Transplantation"},{"key":"1612_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2007.06.008","volume":"125","author":"M Visenti","year":"2007","unstructured":"Visenti M, Granata M, Veneziano ML, Borghese F, Carlesimo M, Pimpinelli F, Fiorilli M, Casato M (2007) Efficacy of low-dose rituximab for mixed cryoglobulinemia. Clin Immunol 125:30\u201333","journal-title":"Clin Immunol"},{"key":"1612_CR29","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s00415-009-5072-z","volume":"256","author":"R Cavallo","year":"2009","unstructured":"Cavallo R, Roccatello D, Menegatti E, Naretto C, Napoli F, Baldovino S (2009) Rituximab in cryoglobulinemic peripheral neuropathy. J Neurol 256:1076\u20131082","journal-title":"J Neurol"},{"issue":"10","key":"1612_CR30","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1136\/ard.2007.081653","volume":"67","author":"D Saadoun","year":"2008","unstructured":"Saadoun D, Resche-Rigon M, Sene D, Perard L, Piette JC, Cacoub P (2008) Rituximab combined with peg-interferon-ribavirin in refractory HCV-associated cryoglobulinemia vasculitis. Ann Rheum Dis 67(10):1431\u20131436","journal-title":"Ann Rheum Dis"},{"key":"1612_CR31","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/rheumatology\/keh470","volume":"44","author":"M Catuogno","year":"2005","unstructured":"Catuogno M, Rezai S, Priori S, Magrini L, Valesini G (2005) Serum sickness associated with rituximab in a patient with hepatitis C virus-related mixed cryoglobulinemia. Rheumatology 44:406","journal-title":"Rheumatology"},{"key":"1612_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/rheumatology\/kel004","volume":"45","author":"L Quartuccio","year":"2006","unstructured":"Quartuccio L, Soardo G, Romano G, Zaja F, Scott CA, De Marchi G, Fabris M, Ferraccioli G, De Vita S (2006) Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroid. Rheumatology 45:842\u2013846","journal-title":"Rheumatology"},{"issue":"1","key":"1612_CR33","first-page":"27","volume":"66","author":"MR Korte","year":"2008","unstructured":"Korte MR, van Heerde MJ, de Man RA, Betjes MHG (2008) Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Neth J Med 66(1):27\u201330","journal-title":"Neth J Med"},{"issue":"1","key":"1612_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcv.2009.10.006","volume":"47","author":"R Uppal","year":"2009","unstructured":"Uppal R, Charles E, Lake-Bakaar G (2009) Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab. J Clin Virol 47(1):69\u201371","journal-title":"J Clin Virol"},{"issue":"8","key":"1612_CR35","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/art.10345","volume":"46","author":"F Zaja","year":"2002","unstructured":"Zaja F, De Vita S, Russo D, Michelutti A, Fanin R, Ferraccioli G, Baccarani M (2002) Rituximab for the treatment of type II mixed cryoglobulinemia. Arthritis Rheum 46(8):2252\u20132254","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1612_CR36","first-page":"1157","volume":"84","author":"F Zaja","year":"1999","unstructured":"Zaja F, Russo D, Patriarca F, Ermacora A, Baccarani M (1999) Rituximab for the treatment of type II mixed cryoglobulinemia. Haematologica 84(12):1157\u20131158","journal-title":"Haematologica"},{"issue":"6","key":"1612_CR37","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/art.10947","volume":"48","author":"GJ Silverman","year":"2003","unstructured":"Silverman GJ, Weisman S (2003) Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum 48(6):1484\u20131492","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1612_CR38","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1182\/blood.V99.3.754","volume":"99","author":"G Cartron","year":"2002","unstructured":"Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H (2002) Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fc\u03b3RIIIa gene. Blood 99(3):754\u2013758","journal-title":"Blood"},{"issue":"3","key":"1612_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard.2006.065565","volume":"67","author":"P Cacoub","year":"2008","unstructured":"Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D (2008) Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis 67(3):283\u2013287","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-010-1612-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1612-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1612-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:15:03Z","timestamp":1659111303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-010-1612-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,31]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1612"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1612-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,31]]},"assertion":[{"value":"8 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}